Castroneves Luciana A, Jugo Rebecca H, Maynard Michelle A, Lee Jennifer S, Wassner Ari J, Dorfman David, Bronson Roderick T, Ukomadu Chinweike, Agoston Agoston T, Ding Lai, Luongo Cristina, Guo Cuicui, Song Huaidong, Demchev Valeriy, Lee Nicholas Y, Feldman Henry A, Vella Kristen R, Peake Roy W, Hartigan Christina, Kellogg Mark D, Desai Anal, Salvatore Domenico, Dentice Monica, Huang Stephen A
Thyroid Program of the Division of Endocrinology (L.A.C., R.H.J., M.A.M., J.S.L., A.J.W., C.C.G., H.D.S., N.Y.L., S.A.H.), Clinical Research Center (H.A.F), and Department of Laboratory Medicine (R.W.P., C.H., M.D.K), Boston Children's Hospital; Thyroid Section of the Division of Endocrinology, Diabetes, and Hypertension (S.A.H.), Department of Pathology (D.D., A.T.A.), and Division of Gastroenterology (C.U., V.D., A.D.), Brigham and Women's Hospital; Harvard Neurodiscovery Center (L.D.); Dana Farber Cancer Institute (R.T. B., S.A.H.); Division of Endocrinology (K.R.V.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115; and Department of Molecular and Clinical Endocrinology and Oncology (C.L., D.S., M.D.), University of Naples Federico II, 80131 Naples, Italy.
Endocrinology. 2014 Oct;155(10):4061-8. doi: 10.1210/en.2013-2028. Epub 2014 Jul 8.
Type 3 deiodinase (D3), the physiologic inactivator of thyroid hormones, is induced during tissue injury and regeneration. This has led to the hypotheses that D3 impacts injury tolerance by reducing local T3 signaling and contributes to the fall in serum triiodothyronine (T3) observed in up to 75% of sick patients (termed the low T3 syndrome). Here we show that a novel mutant mouse with hepatocyte-specific D3 deficiency has normal local responses to toxin-induced hepatonecrosis, including normal degrees of tissue necrosis and intact regeneration, but accelerated systemic recovery from illness-induced hypothyroxinemia and hypotriiodothyroninemia, demonstrating that peripheral D3 expression is a key modulator of the low T3 syndrome.